Baxter International Inc. vs. Treace Medical Concepts, Inc. Common Stock
BAX
Baxter International Inc.
$26.49 +0.57%
VS TMCITreace Medical Concepts, Inc. Common Stock
$4.37 +0.69%
Baxter International Inc. (BAX) comes out ahead, leading on 6 of 8 compared factors.
Size & Scale
| BAX | TMCI | |
|---|---|---|
| Market Cap | $13.62 billion | $282.25 million |
| Revenue (TTM) | $11.47 billion | $205.31 million |
| Net Income (TTM) | $-1,063,000,000 | $-59,516,000 |
BAX leads on 2 of 3 size & scale factors.
Valuation
| BAX | TMCI | |
|---|---|---|
| Price / Book | 2.20 | 4.17 |
| Price / Sales | 1.19 | 1.37 |
BAX leads on 2 of 2 valuation factors.
Profitability
| BAX | TMCI | |
|---|---|---|
| Net Margin | -9.27% | -28.99% |
| Return on Equity | -17.20% | -87.86% |
BAX leads on 2 of 2 profitability factors.
Dividend
| BAX | TMCI | |
|---|---|---|
| Dividend Yield | 0.15% | — |
BAX and TMCI split the dividend factors evenly.
Risk & Sentiment
| BAX | TMCI | |
|---|---|---|
| Short Interest | 1.03% | 0.08% |
TMCI leads on 1 of 1 risk & sentiment factors.
Dig deeper: BAX overview, BAX financials, TMCI overview, TMCI financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.